This study investigates the condition known as atopic eczema in children. Atopic eczema is a skin condition that causes red, itchy patches on the skin. The purpose of this study is to see if this condition improves when another condition, eosinophilic esophagitis (EE), is treated with a type of medicine called proton pump inhibitors (PPIs).

Participants in this study will receive treatment with PPIs to see if their eczema symptoms change. Proton pump inhibitors are medications that reduce stomach acid, which might affect the skin condition indirectly. The study will monitor the response of the eczema to this treatment.

• Who can participate: The study is looking for children aged [specific age range] diagnosed with atopic eczema. Participants must also have eosinophilic esophagitis (EE) as part of the study criteria.
• Study details: Participants will take proton pump inhibitors to see if their atopic eczema improves. A placebo might also be used, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.